<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>bis620</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">bis620</h1>



<div id="team-members" class="section level2">
<h2>Team Members</h2>
<ul>
<li>Lang Ding (ld698)</li>
<li>Shurui Wang (sw2349)</li>
</ul>
</div>
<div id="background-and-motivation" class="section level2">
<h2>Background and motivation</h2>
<div id="data-description" class="section level3">
<h3>Data Description</h3>
<p>The dataset comes from the NCT00364013 study on clinicaltrials.gov
named ‘<a href="https://clinicaltrials.gov/ct2/show/NCT00364013">PRIME:
Panitumumab Randomized Trial In Combination With Chemotherapy for
Metastatic Colorectal Cancer to Determine Efficacy</a>’ This study was
to assess whether panitumumab in combination with FOLFOX chemotherapy
improves PFS compared to FOLFOX alone as first-line therapy for mCRC
among subjects with wild-type KRAS tumors and subjects with mutant KRAS
tumors. The dataset contains 7 tables, which are <code>adae</code>,
<code>adlb</code>, <code>adls</code>, <code>adpm</code>,
<code>adrsp</code>, <code>adsl</code>, and <code>biomark</code>. In our
final project, since we are focusing on the adverse effect and the new
lesion for the patients before or after treatment, we are only going to
use 3 of the 7 tables. Each row of each table represents a record for a
patient with a corresponding <code>SUBJID</code>.</p>
<ul>
<li><p>adsl<br />
This table has 935 rows and 19 columns. It records each patient’s basic
information(age, sex, weight, etc.), primary tumor type, and
treatment.</p></li>
<li><p>adae<br />
This table has 3211 rows and 7 columns. It records each patient’s
adverse events type, System Organ Class(where adverse events happen),
severity grade, and whether this is a continuing event.</p></li>
<li><p>adls<br />
This table has 29118 rows and 11 columns. It records each patient’s
visit day and information on any new lesions they have reported on that
day, along with the reader’s information.</p></li>
</ul>
</div>
<div id="motivation" class="section level3">
<h3>Motivation</h3>
<p>As we examined the dataset, we found that, during the treatment of
the selected chemotherapy, new lesions or adverse events might occur to
an individual. The occurrence of both two might result from the natural
course of cancer or the toxicity of the chosen chemotherapy. However,
the association between them is unknown. During the treatment, lesion
diagnosis might be more expensive than detecting adverse events in
participants. Therefore, we would like to investigate the potential
association between the adverse event and lesion to know if the
occurrence of an adverse event might indicate possible lesions when
using the chosen chemotherapy in this clinical trial.</p>
</div>
</div>
<div id="research-question" class="section level2">
<h2>Research question</h2>
<p>In this study, instead of choosing the actual name of adverse events,
we choose the variable of the location where adverse events happened,
which is called “System Organ Class”. We think that the adverse events
happened in the system organ class of “Skin and subcutaneous tissue
disorders” and the lesion in the liver might be associated with the
toxicity of the chosen chemotherapy since the liver is a crucial organ
to process poisons in the body, and the skin system with active cell
division activity is susceptible to the nature of chemotherapy that
suppresses this activity. As a result, we would like to investigate if
there exists an association between them. Therefore, We hypothesized
that <strong>a patient in the study who has a higher level of “Skin and
subcutaneous tissue disorders” adverse effect would have a higher chance
of getting new lesions on a specific site during the
treatment.</strong></p>
</div>
<div id="data-cleaning-and-exploration" class="section level2">
<h2>Data cleaning and exploration</h2>
<div id="data-cleaning" class="section level3">
<h3>Data cleaning</h3>
<ul>
<li>Joining the table</li>
</ul>
<p>Since our research question is about patients with “Skin and
subcutaneous tissue disorders” adverse effects, and we want to see the
variation in different severity levels, we filtered the
<code>adae</code> table with AESOC = “Skin and subcutaneous tissue
disorders”, and dropped missing values in <code>AESEVCD</code>(severity
levels). Then, we joined adae with adsl and adls table, by patients’
<code>SUBJID</code>. This new dataset is saved as
<code>lesion</code>.</p>
<ul>
<li><code>LSSITE</code></li>
</ul>
<p>There were 1505 NA and 601 empty values in the LSSITE column in
<code>lesion</code> dataset after joining the above three tables. This
is because not all patients have a new lesion. We have replaced them
with “None” before saving the .rda file and the resulting lesion data
has no missing values.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="fu">data</span>(lesion)</span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">sum</span>(<span class="fu">is.na</span>(lesion<span class="sc">$</span>LSSITE)))</span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; [1] 0</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a><span class="fu">print</span>(<span class="fu">sum</span>(lesion<span class="sc">$</span>LSSITE <span class="sc">==</span> <span class="st">&quot;&quot;</span>))</span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; [1] 0</span></span></code></pre></div>
</div>
<div id="data-preprocessing" class="section level3">
<h3>Data preprocessing</h3>
<p>The data preprocessing steps are done in the data_processing()
function. The user can input a specific LSSITE name they want to check
along with the lesion data to the function, and get processed lesion
data with 2 new columns added. The first added column is
<code>new_ls</code>, which has two categories: the specific user input
LSSITE, and <code>Other</code>. The second added column is
<code>level</code>, which transferred the <code>AESEVCD</code> column
into 2 categories. <code>level</code> = ‘LOW’ when <code>AESEVCD</code>
= 1, and <code>level</code> = ‘HIGH’ for <code>AESEVCD</code> = 2, 3, or
4. After data preprocessing we should be able to check the variation in
different <code>LSSITE</code> values. For example, if we want to check
the lesion on the liver, we could preprocess the data with the following
command: <code>data_processing(lesion, &quot;Liver&quot;)</code>.</p>
</div>
<div id="data-exploration" class="section level3">
<h3>Data Exploration</h3>
<p>There are two treatment groups in this study. We consider “FOLFOX
alone” as the control group and “Panitumumab + FOLFOX” as the treatment
group.</p>
<p>Since we would like to investigate the potential association between
the adverse effect and the site of the lesion that occurred in the
course of the clinical trial, we made the summary table as follows:</p>
<pre><code>                           Blood and lymphatic system disorders 
                                                              2 
                                     Gastrointestinal disorders 
                                                              1 
           General disorders and administration site conditions 
                                                             26 
                                        Hepatobiliary disorders 
                                                              9 
                                    Infections and infestations 
                                                            166 
                 Injury, poisoning and procedural complications 
                                                             23 
                    Neoplasms benign, malignant and unspecified 
                                                              8 
                       Reproductive system and breast disorders 
                                                              1 
                Respiratory, thoracic and mediastinal disorders 
                                                              1 
                         Skin and subcutaneous tissue disorders 
                                                           2929 
                                             Vascular disorders 
                                                             45 
                                                             </code></pre>
<p>Because the majority type of adverse effect is “Skin and subcutaneous
tissue disorders”, we think that it would be interesting to examine the
association between the location of lesions and the severity level of
“Skin and subcutaneous tissue disorders”. The following is the summary
of the total counts of lesion sites that have occurred during this
clinical trial.</p>
<table>
<thead>
<tr class="header">
<th align="left">LSSITE</th>
<th align="right">Freq</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Abdomen</td>
<td align="right">3626</td>
</tr>
<tr class="even">
<td align="left">Bone</td>
<td align="right">365</td>
</tr>
<tr class="odd">
<td align="left">Central Nervous System</td>
<td align="right">16</td>
</tr>
<tr class="even">
<td align="left">Chest</td>
<td align="right">218</td>
</tr>
<tr class="odd">
<td align="left">Gastrointestinal</td>
<td align="right">3095</td>
</tr>
<tr class="even">
<td align="left">HEENT/Neck</td>
<td align="right">1</td>
</tr>
<tr class="odd">
<td align="left">Liver</td>
<td align="right">61724</td>
</tr>
<tr class="even">
<td align="left">Lymph Nodes</td>
<td align="right">21726</td>
</tr>
<tr class="odd">
<td align="left">Musculoskeletal</td>
<td align="right">210</td>
</tr>
<tr class="even">
<td align="left">None</td>
<td align="right">2106</td>
</tr>
<tr class="odd">
<td align="left">Other</td>
<td align="right">381</td>
</tr>
<tr class="even">
<td align="left">Pelvic Site</td>
<td align="right">1547</td>
</tr>
<tr class="odd">
<td align="left">Pulmonary</td>
<td align="right">7561</td>
</tr>
<tr class="even">
<td align="left">Skin</td>
<td align="right">208</td>
</tr>
<tr class="odd">
<td align="left">Spleen</td>
<td align="right">161</td>
</tr>
</tbody>
</table>
<p>As we can see, it is very rare that lesions occurred on HENNT/Neck in
this clinical trial. However, lesions that occur are usually found in
sites like “Liver” and “Lymph Nodes”. Therefore, in the following steps,
we use plots and tests to examine whether there is a significant
difference in the number of lesions on a specific site within the
control group (FOLFOX alone) and the treatment group (Panitumumab +
FOLFOX).</p>
<p>In the following, given a specific lesion site, we used the function
<code>plot_lesion</code> to graph a side-by-side bar plot facet-wrapped
by treatment (ATRT) and level of the adverse effect “Skin and
subcutaneous tissue disorders” to check and compare the number of
lesions found on this specific site.</p>
<p>We checked bat plots for all lesion sites to see if the ratio between
the number of lesions occurred on this site is roughly different due to
the level of “Skin and subcutaneous tissue disorders”.</p>
<p><strong>Similar Ratio</strong></p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a><span class="fu">plot_lesion</span>(lesion, <span class="st">&quot;Liver&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>This is the bar plot to check the number of lesions that occurred on
“Liver”. As we can see, in both the control group and treatment group,
the proportion of the number of lesions that occurred in “Liver” does
not change in LOW level “Skin and subcutaneous tissue disorders” and
HIGH level “Skin and subcutaneous tissue disorders”. In the control
group, the proportion of lesions occurring on “Liver” is around 67% of
the total number of lesions that occurred. In the treatment group, the
proportion of lesions that occurred on “Liver” is around 60% of the
total number of lesions that occurred. Therefore, the number of lesions
that occur on “Liver” does not seem to be affected by the level of “Skin
and subcutaneous tissue disorders” adverse effect.</p>
<p><strong>Ratio Changed</strong></p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" aria-hidden="true" tabindex="-1"></a><span class="fu">plot_lesion</span>(lesion, <span class="st">&quot;Pulmonary&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<p>This is the bar plot to check the number of lesions that occurred on
“Pulmonary”. This is an example of ratio changing where the proportion
of lesions occurring on “Pulmonary” decreases when the level of “Skin
and subcutaneous tissue disorders” changes from LOW to HIGH. In this
case, it seems that the number of Pulmonary lesions would decrease when
the patient is having a HIGH level of “Skin and subcutaneous tissue
disorders”. However, since it does not show if the effect is
significant, we need a more rigorous test which is the logistic
regression conducted in the Analysis section below.</p>
</div>
</div>
<div id="analysis" class="section level2">
<h2>Analysis</h2>
<p>After investigating through all possible lesion sites, the results
can be breakdown into the following four cases:</p>
<div id="case-1-treatment-and-the-interaction-term-are-both-statistically-significant.-the-severity-level-is-not-statistically-significant." class="section level3">
<h3>Case 1: Treatment and the interaction term are both statistically
significant. The severity level is not statistically significant.</h3>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" aria-hidden="true" tabindex="-1"></a><span class="fu">logit_analysis</span>(lesion, <span class="st">&quot;Liver&quot;</span>)</span>
<span id="cb5-2"><a href="#cb5-2" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; [1] &quot;The lesion site you chosed is Liver.&quot;</span></span>
<span id="cb5-3"><a href="#cb5-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-4"><a href="#cb5-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb5-5"><a href="#cb5-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; glm(formula = new_ls ~ level * ATRT, family = &quot;binomial&quot;, data = df)</span></span>
<span id="cb5-6"><a href="#cb5-6" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-7"><a href="#cb5-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Deviance Residuals: </span></span>
<span id="cb5-8"><a href="#cb5-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;    Min      1Q  Median      3Q     Max  </span></span>
<span id="cb5-9"><a href="#cb5-9" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; -1.509  -1.324   1.011   1.011   1.038  </span></span>
<span id="cb5-10"><a href="#cb5-10" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-11"><a href="#cb5-11" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Coefficients:</span></span>
<span id="cb5-12"><a href="#cb5-12" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;                                    Estimate Std. Error z value Pr(&gt;|z|)    </span></span>
<span id="cb5-13"><a href="#cb5-13" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Intercept)                         0.68390    0.02454  27.866   &lt;2e-16 ***</span></span>
<span id="cb5-14"><a href="#cb5-14" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH                           0.06776    0.05700   1.189   0.2346    </span></span>
<span id="cb5-15"><a href="#cb5-15" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ATRTPanitumumab + FOLFOX           -0.27860    0.02608 -10.682   &lt;2e-16 ***</span></span>
<span id="cb5-16"><a href="#cb5-16" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH:ATRTPanitumumab + FOLFOX -0.13545    0.05856  -2.313   0.0207 *  </span></span>
<span id="cb5-17"><a href="#cb5-17" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ---</span></span>
<span id="cb5-18"><a href="#cb5-18" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Signif. codes:  0 &#39;***&#39; 0.001 &#39;**&#39; 0.01 &#39;*&#39; 0.05 &#39;.&#39; 0.1 &#39; &#39; 1</span></span>
<span id="cb5-19"><a href="#cb5-19" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-20"><a href="#cb5-20" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Dispersion parameter for binomial family taken to be 1)</span></span>
<span id="cb5-21"><a href="#cb5-21" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-22"><a href="#cb5-22" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Null deviance: 138601  on 102944  degrees of freedom</span></span>
<span id="cb5-23"><a href="#cb5-23" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Residual deviance: 138377  on 102941  degrees of freedom</span></span>
<span id="cb5-24"><a href="#cb5-24" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; AIC: 138385</span></span>
<span id="cb5-25"><a href="#cb5-25" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb5-26"><a href="#cb5-26" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Number of Fisher Scoring iterations: 4</span></span></code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAqAAAAGACAMAAABFpiBcAAAA81BMVEUAAAAAAC4AADoAAFIAAGYAM3MAOjoAOmYAOpAAXJEAZpAAZrYAgP86AAA6AC46ADo6OgA6Ojo6OmY6OpA6ZpA6ZrY6gK86kLY6kNtmAABmAC5mADpmOgBmOjpmXC5mZmZmgHNmkLZmkNtmo5Fmo8xmtttmtv+QMwCQOgCQZgCQZjqQkGaQtpCQttuQxcyQ27aQ2/+2XAC2ZgC2Zjq2ZpC2xXO229u22/+25a+25cy2/7a2///bgC7bkDrbtmbbtpDb27bb5ZHb5czb/9vb////AP//o1L/tmb/xXP/25D/27b/5ZH/5a//5cz//7b//9v///+8dClSAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAXOUlEQVR4nO2dC5vbxnVAWUWu19EyjdNY1VZu3STOetOm6Ypp6zYSmtZZLbWWvcv//2s6D7wuMBiQGIC8BM75PpkkCGIHF8fzAnCx2gEoZnXqAgDEQFBQDYKCahAUVIOgoBoEBdUgKKgGQUE1CNpLtiq4uNs9/XG9Wn3h/9ux/tO/v2388hffmqU39ucdK0InCNqLEHRrX1/5/4ZX//7L501BV89uA4LWVoROELQXIWhmZcv/G2azagtqftkWtLYidIKgvWQ1kTauPvx5USv+0bx84bX7H7Pwr3+br5H/IP/l91dm5ULQP/+DWe9Xd3JF6ARBe+kU9PHK1Y6fvi2+sM1+QFBX4eaCZmVdjKB7gaC9VA319U408aaN/nb3sLadUdMp/bs7U1Ma4UQT797+r13uBTVru36C/Q1N/D4gaC9dgpoK9NUut9DLlv3yP3v6oPmXm4bJ0AmC9tIlqKkNizF6fQQUErQYxRfrud8j6D4gaC/1Pmhd0O2qLuiLYo22oM9+WcyDmkrXrbe1siPoPiBoL12Cmhr0Ol/aWYNWv6QGHQaC9tIlaFEdWrxs21/8a1xQ+qAHg6C9VH1QI5QcxT/7rZ3k9CeYvrD1o6lTa5P4bUHro/jYbD8UIGgvnYLm86BOs3we9IXrXzbnQS2tedD6itAJgvbSKeju+382A3k7AtrlZ5J+bd7Y00uffpv/siWoP5P0651cETpBUFANgoJqEBRUg6CgGgQF1SAoqAZBQTUICqpBUFANgoJqEBRUg6CgGgQF1SAoqAZBQTUICqpBUFANgoJqEBRUg6CgGgQF1SAoqAZBQTUICqpBUFANgh6LTfUMBZdZ9LpclrlEuE83Lzp/e24U+2L2b+tysLgsQXZna9/stykEPRbVIcmsnA9rc6Qyn+vuK/vV41XHc23OkKagbo+fbszeIqhaykPy8De39sUK+bA2B+7x9e/tknzxLGgI6nbTL0VQtZSHZJM35ZnNuGwfwHDxl5vrojadBw1Bi13PrhFUL8UhKZtyd+hsO//CvWzm0wVtCPp08yr0zX6bQtBjUQmaJw63Dd/WpgUvX2aDTeWb50Hd2udJXYe+2W9TCHosgoKajufj61v7MqcuaKMG9Xu8cQlWqUHVEmziTb25tc9Q9i+zoSlosccIqpjQIMl8eJW9cMuyGXVBuwZJCKqZaprJT7r4emX7U9f33H765Yy6oB3TTAiqmtBEvXn53PU9H9azeuJHe6Le/s+4WTEPqpjyeci1U532ULojlb/MhfCpTjvRi6AwLxAUVIOgoBoEBdUgKKgGQUE1CAqqOaagy/qfoXdvCceUv9P+t04PggoQVBsIKkBQbSCoAEG1gaACBNUGggoQVBsIKlAo6AogwukF/RHqEA8BgmqDeAgQVBvEQ4Cg2iAegnMW9M3qpfnvx6u8N/2T//rGv3lZW/bfgV95vjbvP6zzNz+++eS7yNcf1v7rd37lko9X8vMYhOORtK+fBTboin4/qPgf1p0/GzO4njMW9MPP/rE4Jh9+9gfz3x++cUfi3u+oXxaIYRGtPCQf1p+JGAa/vnd+fFi/lNs6mqBJ+/rxqtonwcDixwQdMbieMxb03U/+o4iUOGj5S7+g+Rofr14GY1j/+sc3xo98wzWOJmjavt7/VfjrKQVND67nfAU1e1TulDhoeRj6BX2T//qdWRKIYf1rE8nPjCVlI/rGN0++nXQtrXn/myvfZr3zCwYSikfivjqjyiL7Ypqi20b2k/+78vvxYW2Xv7TLvvb71VxYbuLD+p/W9T2s/fVRgivDcbaC2mrhXV41xGsV19tZrfJ1yyD5/3vzLbVjKL72R6WsOGx47d+2B/LeHdDPzL+8QPZfR3u1D6F4JO6r28GyyH5btujFP++iXW47skaV4MJyE25pbQ9DgiYEtxGOsxXU7myxn+KgvduzD1o2cLaCCcWw9rXbbHlEPv79H/xis84P39jF9/aIv3QLfZnuOyqEfkLxSNtX979PVeSimE1BX+b9wPzL9sJiE97NqsoLCzo0uM1wnKugPkpvfJSKg1aNESMHrVipI4bBr93GhXP3ZTvpR6LlQS3qhKG900A8Uve1qK3qrXdb0K/zUgtBawvLTfj3ecc2r7LzgowU3Ho4zlXQd7UZi3qt4geGsYM2rBV6Y3prZTfe/HE3aikFzY+4E7ResAEE4pG+r6LIQwUtNuH/Wq1bkdzEi+A2wnGmguZN3MerWh/ML7tf1ZtC9y7cBz2oH297msWWq0PWXYMOpx2PMfa1XuSBgpYfRA36Y1jQ4cFthmOwoEWW5tSk/sMELcLjhw6iX/Ymb3v6p5l8s9U5E1L7Op/Py/+o62D6wVG9D1od+RTa8RhjX+tFbgj6UupX9qObC8tN5H3Q5pSR/IODg9sMx1BBfao8w3aV9uCeYYIWu+qDJQ5aPi895kT9D9+4LlIx4+1rIncWpz6Kz+ednEcd4d6DdjzG2FdR5ErQl2ZDn3xnuoDSxeDCchNuFH8f7MOMENxmOAYKWnskQ5aWEnCQoNUYxA0d5NygHxLuIWj9bFwxnAh9bY+VW3C/Kv6CaUTf5LVmOQ9aTIy+C5933JNWPMbZV1HkoqJ/s/rkO3uq9DfN7mZwYbEJPw8abCfGCG4jHAMFrT2SYZvWyHNxhIR4CM60Bp0xxEOQ0AfNq9DkPihAhKGC+nTNq/0ftXTAphcN8RAomAedbtNnCfEQTCPodrUqHkexzWvqa7F0+KZnD/EQTCKofWTDtu7i49WLwNIhm54/xEMwhaB+hF9/LG/mnlHfXDpg0zPivaBavtR4dDCFoP6JYbUHmz+sXwWWDtn0/HjfXLDweDSZRFD3VLTa/P3Gvm0tPWweYa4gaJw9LQl+b+vE0KPAfEez6m7mj5tsLI1uejkgaJyUGnRfQeufEbQBgsaZQtBmY+7XaTXxh5VgriBonEkElcOh/EH1DJKCIGicKQRtTCjljwFnmikIgsaZQtDGlHzxjon6EAgaZxJBd5k/qemf+l226hmnOtsgaBwuFjkxCBoHQU8MgsZB0BODoHEQ9MQgaBwEPTEIGidB0Np9c0cowVxB0DgJgtbuPD5CCeYKgsZJaeITb4g/rARzBUHjJNWg+aV6iYkbUn58/iBoHAZJJwZB4yDoiUHQOEmCmkb+4m6TOJZf+AFB0DhJg6Rnt9nFXX6559QlmCsIGidxHtQmDmtfgzxFCeYKgsZJnAe1gqamX0z58fmDoHFGqEHDl4SOXYK5gqBx0vugZR7GaUswVxA0TuooPniR/BQlmCsIGod50BODoHEQ9MQgaJwUQcd5UtLCDwiCxkkRdMPVTOkgaJykeVAuWE4HQeNMc8GySPb9sF6tXD6RzGcCH1aCuYKgcZIm6ltpbHJEDpHtxZ1PAZ7ZpW1DF35AEDROamaRECILk/+QPX/rfSY3k+Tysrlk2fFoMVTQ8nL6wChe5LHzWRd3RYWLoILL3fumoYuOR5sp5kFFJtDt8z8Zl10t2mjiSQFu/DRNfMPQJccjQEIK8MfXt+61dTWTyKWcrdwTPmzFyXOSGlxaEDRKyig+F7R1PagU1H8w69hpU/e8j0ElmA+XJTTx/QwWdFP1QZvOiSbe62u6pUvPsFzTUixtrreUeOzJCDVoC6Gi99Q4u8yHKFyGvaxgminOFIMkMc3kp/ONpl7bhTxEoU/LCgSNkzRR3/U0bjFRby+6d8rOvw/aW10GQNA4wwXNfN8za3VBd40U4Nuim7oJ9FfncEAGaFmBoHEGC1rWkF3nkw4vQdfjVXUypLoMgKBxhgpaOxE/9k1zutUcR8sKBI0z/FRnWW+OfduxRkFHqi4DIGgcBI0xmZYVCBqHJr7NdNVlAASNo2mQlHMiQY+qZQWCxplmmimpBMcV9DRaViBonEkm6tNKcAxBT1RdBkDQOArvi59QUDVaViBonCUIqqe6DICgcWYsqGYtKxA0zuwEVV1dBkDQOHMR9My0rEDQOOct6LlVlwEQNM5ZCnr+WlYgaJwRcjNlaUlsm5vu1G4G1WUABI2jrgZt3ec4Sy0rEDSONkGLVAbzrC4DIGgchYIuQcsKBI2jTdBQKoNZg6BxpkgellaCBdWeFgSNM7gGfbqJeBlOYFu+iW/65BcsHxUEjTO8ie/OX9uRwLZ807NpBIWKhD5oIFuypyuBbf6mb9MIChWT5AcNJrAt3/RtGkGhYhJBgwlsq0y2PZtGUKiYQtBwAttaJtt8mx25cxEUKhIyLHcSTmBbZbLt2TSCQsXkTXyZwLZ807dpBIWKyQdJVQLb4k3fphEUKqYQNJzAtnzTt2kEhYoUQW1NGcx7E05gW77p2fRCBO1KNomggkkE7Uhgu90vge1CBO0CQQXTCJpUAgSFCgTVBoIKEFQbCCrQJOh55aifCgQVaBIULMRDoO6Wj8VDPAQIqg3iIUBQbRAPAYJqg3gIEFQbxEOQIGjgvPqEJVgMxEOQlDws7fkzh5VgMRAPQUoTn/iIucNKsBiIhyCpBp0ks8jSIR4CBknaIB4CBNUG8RAkCWoa+Yu7zdiPQlw4xEOQNEh6dptd3BWZwCcuwWIgHoLEeVB7n1E73dIUJVgMxEOQOA9qBU2cbeKASIiHYIQaNPGSUA6IhHgI0vugWSALYziBrSEgMwdEQjwEqaP44DOSwgls7fvA4+U5IBLiIZg8s0g9b62blkra9AIgHoLJczPVkzFlF79D0D6IhyBpFN+RpD6cwNYtpw/aC/EQpNSgm3APtCOBrWvs64LumZp0aRAPQWICW5tuqfVomXAC264pKQ6IhHgI0vug7QcmhRPYuqUI2gvxECQKGqxBwwlss7yu7s2wvHCIhyDpTFJHHzScwNZ9ogbthXgIphjFdySwtSBoL8RDMM0Fy+EEtjsE3QPiIeCKem0QD8FQQR+vXnHT3CQQDwE1qDaIhwBBtUE8BCMIyhX1o0I8BAiqDeIhQFBtEA8BgmqDeAgQVBvEQ4Cg2iAeguET9asSBB0T4iFgHlQbxEOAoNogHgIE1QbxECCoNoiHAEG1QTwECKoN4iFAUG0QD0HSPUn+Rg4S2I4K8RBQg2qDeAimETSYH9TdptzOZ88BkRAPQWp+0OBTPoL5QZ9uzJKsleWBA9KAeAhSBO16ykc4P6jIN3J4CRYD8RAkZRbpeMpHZ37Q3a6qWA8twWIgHoKkUXzHUz668oNaNtSgPRAPwQg1aCtbSEd+UPdVbZREftAgxEOQkh+06ykfHflB7Ut7jMQBaUA8BKmj+FB+u3B+0J2sPw8twWIgHoIp5kHD+UFtax96qicHREI8BCmDpNe37rU1SOrIDxp64tf+JVgMxEMwgqDtqc1gftCHdfipyBwQCfEQDBZ0U9001xYvlB80TwHOPGgPxEMwQg16nBIsBuIh4GombRAPAYJqg3gIhiduIMPyNBAPATWoNoiHAEG1QTwEwwV185rb8KO8JijBYiAegsGCuvOZ29V1fmJz8hIsBuIhGD5Rb+fg3dWdm64Hzo1agsVAPAQJo/jyTBGj+DEhHoLhgl4Xd8Yj6KgQD0GSoPl1de3nb05QgsVAPARJfdCsuiJk8hIsBuIhGCzo9tnt45WtO9u3wU1SgsVAPATD50G3q5Xx82Gd1sBzQJoQDwFnkrRBPAQIqg3iIUBQbRAPAYJqo4rHe8EJi3RKEFQbzXgs1cycI+YH7bj0CUElCCpIEdRlpA1dUR/MDyqXHlyCxdCIx+XlaYqhhRRBu6bow/lBxdLDS7AYZDwud++XbWhS+sVwJoaO/KAksN0PEY9L28Qv2tDE/KBBwvlBxVK3TdIvhmgKemk5VWFOT0L6xc6rRML5QcXSnk0vmWATf1lymkKdjpQ+6DacDawjPyiC7kfPIGlppiY18R33xYfzg7aa+MNKsBj2nWZaSKV6vPygDJL24/B50FmbOoWg4fygTDPtR8JE/Rwr1SRB7Tmi0MmhYH5QJur3Y5QzSfMxNW2Q5ObgA0OlUH7QcumwEiyGcS8WOftKNUFQ32Zz09zITBWPMzV1hIl6bjselcnjcV6VKjWoNo4Yj3MwdZo+6AQlWAyniIfiSnWSUfwUJVgMp42HOlO5ol4bSuKhpVJFUG2oi8dpVUVQbSiOxylMTUi/yEMUJuEc4nHESpUaVBvnFY/JTUVQbZxpPJIr1Y4TuymC2puSMpdCLIUzPSCTcfbxSDK1dclB0l2dF3cP6xfkqB+X+cRjSKU6pqD2XLy964Nz8aMyx3jsb+rYgtpb49sXyR/EHA9ICrOOR1+l2l6e1MS/sDmWXdaQBGZ9QAawkHgETQ2kqUgbJK2e3aamqF/KAdmbpcWjVqmG0lQwzaSN5cajtLTO9Nnt/AknW81m5rV9ad5yD0iYJcdj5Cbeundxt2lnaBK3x5XJmWwKh0CuhyUfkBCLjse4gyTjYGYHSU1D5Q3GxSyU76xy23Efy47HmNNM1kN7u0drmkmmaMheFKsj6D4sOx5jz4NaQVsT9TLJzebz/LZjmvi9WHY8pqhBN82T8SJNWP44OvfUWXl/COkXgyw7Hm1Bh6dfzPug7ZvmAnnsbHVqzzo9rFtDqmUfkDbLjseoF4v4GaT2TXOBPHY2ux3Jw/ZiqfGY4HK7LgIqGmfJD7ofxEMweXY7b6upTss3KZteAMRDMIKgbefERL0T1Q6S6IPuBfEQTCKozG63Kc5wboo0d0NKsBiIh2AaQQ8qAUCEkwt60N+aH717SzhSf4egKSCoAEG1gaCC0QQt04qsUjOL9P+tWYOggilq0LHhiBy2wqxAUG0gqABBtYGggnMQFOBgEBRUg6CgGgQF1SAoqAZBQTUICqpBUFANgoJqJhS0dlu9e7Tidbksc9ffJ+d3VESxL2b//C0x7pobu7O1b05XvDPmKIK6O+xt1vv8jtDNV/ardu6n86UpqNvjpxuztwiaxjEEzdPgWSHdHaCPr39vl5TZ8WZAQ1B/o6tbiqBpHEPQIq9YkTFve/GXm+tQqofzpSFosevZNYImcgRBy6bcHboXLi2efUl8yo0qpKA+f0Drm5OU7Nw5iqB5jifb8G0v7p5uypfZ8HST34TgBC33WH5zwvKdL8cW1HQ8H1/f2pc5dUEbNajf4427aYYaNI1jN/Gm3jS1Z/EyG5qCFnuMoKkceZBkc+VkPiFzNqMuaNcgCUGTOco0k5908fXK9qeu77n99MsZdUE7ppkQNJ0jT9Sbl89d3/Nh3U4/esa0J+pdHsAV86CpTCmoH73aI1We6rSH0h2p/GUuhE912oleBE2Di0VANQgKqkFQUA2CgmoQFFSDoKAaBAXVICioBkFBNQgKqkFQUA2CgmoQFFSDoKAaBAXVICioBkGHU16U3Lfa9W63lTe49F6+XL9zedEg6GC2Ph3aXreuNH1D0H1B0MH4m1X3y9GHoENB0KEIMzN385W/mdPelOQ/7x5f/8vq+Z+uru09WRe/s+tnzTuUun6JoB4EHcx2VRqauVuNX3lnjXz5Z6OZEdG6Zv9tXTJG710paPcvEdSBoMOx9aIbI+V3/D9/axP2mQ/lZ/emENT+K/L9yKwrwV8iqANBk3i6WZkqz99pbJppV1E+uxWfSzltpzXLxSxTj0R/CQiazub5222ewO7aOmhvjS8+S0FNxbjJkzaVgkZ/CQg6nDK9TVHvuQ92SLQrP0tBH1//2+v8C1mDdv0SEHQ4xShedBgfr75yncnr4mNd0Kebz8t8as3UlMFfAoImsHU5abd2UsiOvf2U/cYN7YvPNUFt2+4zNlnEKL7zl4CgKbhTnb5NzoqTnv70UvG5FNToZ5SscvZWeativwQEPSoPf0sCsUNB0COSzefBUEcDQY/Gw5oMjIeDoKAaBAXVICioBkFBNQgKqkFQUA2CgmoQFFSDoKAaBAXVICioBkFBNQgKqkFQUA2CgmoQFFSDoKAaBAXVICioBkFBNQgKqvl/hVtnpcOaowMAAAAASUVORK5CYII=" /><!-- --></p>
</div>
<div id="case-2-treatment-is-statistically-significant.-neither-the-severity-level-nor-the-interaction-term-is-statistically-significant." class="section level3">
<h3>Case 2: Treatment is statistically significant. Neither the severity
level nor the interaction term is statistically significant.</h3>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" aria-hidden="true" tabindex="-1"></a><span class="fu">logit_analysis</span>(lesion, <span class="st">&quot;Lymph Nodes&quot;</span>)</span>
<span id="cb6-2"><a href="#cb6-2" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; [1] &quot;The lesion site you chosed is Lymph Nodes.&quot;</span></span>
<span id="cb6-3"><a href="#cb6-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-4"><a href="#cb6-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb6-5"><a href="#cb6-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; glm(formula = new_ls ~ level * ATRT, family = &quot;binomial&quot;, data = df)</span></span>
<span id="cb6-6"><a href="#cb6-6" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-7"><a href="#cb6-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Deviance Residuals: </span></span>
<span id="cb6-8"><a href="#cb6-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Min       1Q   Median       3Q      Max  </span></span>
<span id="cb6-9"><a href="#cb6-9" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; -0.7112  -0.7112  -0.6872  -0.5879   1.9187  </span></span>
<span id="cb6-10"><a href="#cb6-10" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-11"><a href="#cb6-11" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Coefficients:</span></span>
<span id="cb6-12"><a href="#cb6-12" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;                                    Estimate Std. Error z value Pr(&gt;|z|)    </span></span>
<span id="cb6-13"><a href="#cb6-13" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Intercept)                        -1.66793    0.03171 -52.597   &lt;2e-16 ***</span></span>
<span id="cb6-14"><a href="#cb6-14" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH                           0.09065    0.07119   1.273    0.203    </span></span>
<span id="cb6-15"><a href="#cb6-15" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ATRTPanitumumab + FOLFOX            0.34476    0.03344  10.310   &lt;2e-16 ***</span></span>
<span id="cb6-16"><a href="#cb6-16" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH:ATRTPanitumumab + FOLFOX -0.01317    0.07296  -0.181    0.857    </span></span>
<span id="cb6-17"><a href="#cb6-17" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ---</span></span>
<span id="cb6-18"><a href="#cb6-18" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Signif. codes:  0 &#39;***&#39; 0.001 &#39;**&#39; 0.01 &#39;*&#39; 0.05 &#39;.&#39; 0.1 &#39; &#39; 1</span></span>
<span id="cb6-19"><a href="#cb6-19" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-20"><a href="#cb6-20" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Dispersion parameter for binomial family taken to be 1)</span></span>
<span id="cb6-21"><a href="#cb6-21" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-22"><a href="#cb6-22" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Null deviance: 106103  on 102944  degrees of freedom</span></span>
<span id="cb6-23"><a href="#cb6-23" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Residual deviance: 105917  on 102941  degrees of freedom</span></span>
<span id="cb6-24"><a href="#cb6-24" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; AIC: 105925</span></span>
<span id="cb6-25"><a href="#cb6-25" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb6-26"><a href="#cb6-26" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Number of Fisher Scoring iterations: 4</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="case-3-the-severity-level-treatment-and-interaction-term-are-all-statistically-significant.-the-coefficient-for-high-level-is-negative." class="section level3">
<h3>Case 3: The severity level, treatment, and interaction term are all
statistically significant. The coefficient for high level is
negative.</h3>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" aria-hidden="true" tabindex="-1"></a><span class="fu">logit_analysis</span>(lesion, <span class="st">&quot;Pulmonary&quot;</span>)</span>
<span id="cb7-2"><a href="#cb7-2" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; [1] &quot;The lesion site you chosed is Pulmonary.&quot;</span></span>
<span id="cb7-3"><a href="#cb7-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-4"><a href="#cb7-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb7-5"><a href="#cb7-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; glm(formula = new_ls ~ level * ATRT, family = &quot;binomial&quot;, data = df)</span></span>
<span id="cb7-6"><a href="#cb7-6" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-7"><a href="#cb7-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Deviance Residuals: </span></span>
<span id="cb7-8"><a href="#cb7-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Min       1Q   Median       3Q      Max  </span></span>
<span id="cb7-9"><a href="#cb7-9" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; -0.4617  -0.3889  -0.3816  -0.3816   2.3150  </span></span>
<span id="cb7-10"><a href="#cb7-10" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-11"><a href="#cb7-11" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Coefficients:</span></span>
<span id="cb7-12"><a href="#cb7-12" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;                                    Estimate Std. Error z value Pr(&gt;|z|)    </span></span>
<span id="cb7-13"><a href="#cb7-13" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Intercept)                        -2.18505    0.03844 -56.848  &lt; 2e-16 ***</span></span>
<span id="cb7-14"><a href="#cb7-14" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH                          -0.42353    0.10247  -4.133 3.57e-05 ***</span></span>
<span id="cb7-15"><a href="#cb7-15" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ATRTPanitumumab + FOLFOX           -0.39824    0.04200  -9.483  &lt; 2e-16 ***</span></span>
<span id="cb7-16"><a href="#cb7-16" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH:ATRTPanitumumab + FOLFOX  0.46276    0.10561   4.382 1.18e-05 ***</span></span>
<span id="cb7-17"><a href="#cb7-17" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ---</span></span>
<span id="cb7-18"><a href="#cb7-18" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Signif. codes:  0 &#39;***&#39; 0.001 &#39;**&#39; 0.01 &#39;*&#39; 0.05 &#39;.&#39; 0.1 &#39; &#39; 1</span></span>
<span id="cb7-19"><a href="#cb7-19" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-20"><a href="#cb7-20" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Dispersion parameter for binomial family taken to be 1)</span></span>
<span id="cb7-21"><a href="#cb7-21" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-22"><a href="#cb7-22" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Null deviance: 54039  on 102944  degrees of freedom</span></span>
<span id="cb7-23"><a href="#cb7-23" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Residual deviance: 53954  on 102941  degrees of freedom</span></span>
<span id="cb7-24"><a href="#cb7-24" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; AIC: 53962</span></span>
<span id="cb7-25"><a href="#cb7-25" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb7-26"><a href="#cb7-26" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Number of Fisher Scoring iterations: 5</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
<div id="case-4-the-severity-level-treatment-and-interaction-term-are-all-statistically-significant.-the-coefficient-for-high-level-is-positive" class="section level3">
<h3>Case 4: The severity level, treatment, and interaction term are all
statistically significant. The coefficient for high level is
positive</h3>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" aria-hidden="true" tabindex="-1"></a><span class="fu">logit_analysis</span>(lesion, <span class="st">&quot;Gastrointestinal&quot;</span>)</span>
<span id="cb8-2"><a href="#cb8-2" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; [1] &quot;The lesion site you chosed is Gastrointestinal.&quot;</span></span>
<span id="cb8-3"><a href="#cb8-3" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-4"><a href="#cb8-4" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Call:</span></span>
<span id="cb8-5"><a href="#cb8-5" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; glm(formula = new_ls ~ level * ATRT, family = &quot;binomial&quot;, data = df)</span></span>
<span id="cb8-6"><a href="#cb8-6" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-7"><a href="#cb8-7" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Deviance Residuals: </span></span>
<span id="cb8-8"><a href="#cb8-8" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Min       1Q   Median       3Q      Max  </span></span>
<span id="cb8-9"><a href="#cb8-9" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; -0.2891  -0.2546  -0.2546  -0.2466   2.8973  </span></span>
<span id="cb8-10"><a href="#cb8-10" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-11"><a href="#cb8-11" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Coefficients:</span></span>
<span id="cb8-12"><a href="#cb8-12" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;                                    Estimate Std. Error z value Pr(&gt;|z|)    </span></span>
<span id="cb8-13"><a href="#cb8-13" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Intercept)                        -4.18205    0.09517 -43.941  &lt; 2e-16 ***</span></span>
<span id="cb8-14"><a href="#cb8-14" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH                           1.02775    0.15409   6.670 2.56e-11 ***</span></span>
<span id="cb8-15"><a href="#cb8-15" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ATRTPanitumumab + FOLFOX            0.76889    0.09830   7.822 5.21e-15 ***</span></span>
<span id="cb8-16"><a href="#cb8-16" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; levelHIGH:ATRTPanitumumab + FOLFOX -1.09222    0.15876  -6.880 5.99e-12 ***</span></span>
<span id="cb8-17"><a href="#cb8-17" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; ---</span></span>
<span id="cb8-18"><a href="#cb8-18" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Signif. codes:  0 &#39;***&#39; 0.001 &#39;**&#39; 0.01 &#39;*&#39; 0.05 &#39;.&#39; 0.1 &#39; &#39; 1</span></span>
<span id="cb8-19"><a href="#cb8-19" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-20"><a href="#cb8-20" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; (Dispersion parameter for binomial family taken to be 1)</span></span>
<span id="cb8-21"><a href="#cb8-21" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-22"><a href="#cb8-22" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt;     Null deviance: 27788  on 102944  degrees of freedom</span></span>
<span id="cb8-23"><a href="#cb8-23" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Residual deviance: 27706  on 102941  degrees of freedom</span></span>
<span id="cb8-24"><a href="#cb8-24" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; AIC: 27714</span></span>
<span id="cb8-25"><a href="#cb8-25" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb8-26"><a href="#cb8-26" aria-hidden="true" tabindex="-1"></a><span class="co">#&gt; Number of Fisher Scoring iterations: 6</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
</div>
</div>
<div id="interpretation-and-conclusions" class="section level2">
<h2>Interpretation and conclusions</h2>
<div id="interpretation" class="section level3">
<h3>Interpretation</h3>
<p>First, let’s interpret the results in parts:</p>
<ul>
<li><p><strong>Treatment is statistically significant:</strong> The
treatment is associated with the number of lesions on a specific site.
There is a statistically significant difference in the number of lesions
on a specific site between the control group and the treatment
group.</p>
<ul>
<li><strong>The interaction term is statistically significant:</strong>
Given the fact that the treatment is associated with the number of
lesions on a specific site, compared with patients with a lower level of
“Skin and subcutaneous tissue disorders” adverse effect, patients who
have a higher level of “Skin and subcutaneous tissue disorders” adverse
effect would have a statistically significant different number of
lesions on this specific site.</li>
</ul>
<p><strong>Note that we need to make sure treatment is significant
before looking at the interaction term, and we assume there’s no such
situation that treatment is not significant but the interaction term is
significant.</strong></p></li>
<li><p><strong>The severity level is statistically significant:</strong>
The severity level of “Skin and subcutaneous tissue disorders” adverse
effect is associated with the number of lesions on a specific site.</p>
<ul>
<li><p><strong>The coefficient of severity level is positive:</strong>
The higher the severity level, the higher the number of lesions on a
specific site.</p></li>
<li><p><strong>The coefficient of severity level is negative:</strong>
The higher the severity level, the lower the number of lesions on a
specific site.</p></li>
</ul></li>
</ul>
<p>Next, combine them together and interpret different cases.</p>
<ul>
<li><p>Case 1: The treatment is <strong>associated with</strong> the
number of lesions on a specific site, however the severity level of
“Skin and subcutaneous tissue disorders” adverse effect and the
treatment is <strong>not associated with</strong> the number of lesions
on a specific site.</p></li>
<li><p>Case 2: <strong>Neither</strong> the treatment
<strong>nor</strong> the severity level of “Skin and subcutaneous tissue
disorders” adverse effect <strong>is associated with</strong> the number
of lesions on a specific site.</p></li>
<li><p>Case 3: The severity level of “Skin and subcutaneous tissue
disorders” adverse effect and the treatment are <strong>both associated
with</strong> the number of lesions on a specific site. The higher the
severity level, the <strong>higher</strong> the number of lesions on a
specific site.</p></li>
<li><p>Case 4: The severity level of “Skin and subcutaneous tissue
disorders” adverse effect and the treatment are <strong>both associated
with</strong> the number of lesions on a specific site. The higher the
severity level, the <strong>lower</strong> the number of lesions on a
specific site.</p></li>
</ul>
</div>
<div id="conclusion" class="section level3">
<h3>Conclusion</h3>
<p>According to the above interpretations, a higher level of “Skin and
subcutaneous tissue disorders” adverse effect does not necessarily
associate with a higher number of lesions on this specific site. It is
possible that, given a specific lesion site, a higher level of “Skin and
subcutaneous tissue disorders” adverse effect is significantly
associated with a lower number of lesions observed on this site. It is
also possible that the number of lesions is only associated with the
treatment and is not associated with the level of “Skin and subcutaneous
tissue disorders” adverse effect. Moreover, there are cases that neither
the treatment nor the level of “Skin and subcutaneous tissue disorders”
adverse effect, is associated with the number of lesions observed on a
specific site.</p>
<p>In conclusion, our hypothesis is not comprehensive but partially
correct.</p>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
